Tdut Sen. Bill Nelson To Reintroduce Legislation Prohibiting Drug Marketing by Pharmacies
Different Takes: COVID An
stanley quencher d Heart Disease; Denial At The Top; And Help For The VulnerableOpinion experts we
brumate cooler igh in on these public health issues and others.Los Angeles Times:Could COVID-19 Set Off A Wave Of Heart Disease A teacher who was thinking of quitting the profession because of the coronavirus recently contacted me. He had read about the infection triggering a wave of heart disease and about patients who were symptomatic weeks or months after recovering from their initial coronavirus infection. He was concerned about returning to school and the prospect of carrying the virus home and infecting his family. Uan Ashley, 9/17 The Washington Post:Trump Has Taken Up Residence In A State Of DenialDenial is a river that runs through Donald Trump.At Tuesday nights town hall meeting, he denied that he played down the pandemic, saying, in many ways I up-playe
owala usa d it. But Bob Woodward has released an audio recording of him saying, literally, I wanted to always play it down. Trump further denied that he said President Xi Jinping was doing a good job with the coronavirus. I didnt say one way or the other, Trump claimed. Dana Milbank, 9/16 The Guardian:Athens, Georgia, Was My Home. Its Leaders Are Letting Covid-19 Wreak HavocAlthough I now call New York City home, Athens, Georgia, has been a base to me since the late 1970s. Its where I started REM, and it is a place that I have returned to again and again, even as I have travelled and lived in other places around the globe. Sadly, Vpwb Senate Committee Considers Association Health Plan Legislation
Thursday, Jun 11 2009Indian Court Rejects Novartis ; Challenge to Country Patent LawAn Indian court on Monday rejected Swiss pharmaceutical company Novartis challenge to a section of the country s Patents Act that aims to restrict certain kinds of patents, Reuters India reports Murari, Reuters Ind
adidas samba ia, 8/6 . India s patent law, which went into effect in January 2005, allows patents for products that are new inventions developed after 1995, when India joined the World Trade Organization, or for an updated drug that exhibits improved efficacy. Indian Health Minister Anbumani Ramadoss in April urged Novartis to withdraw its challenge over concern that it could dis
owala rupt the global supply of antiretroviral drugs. Novartis also brought a civil lawsuit against the Indian government after the country in January 2006 rejected the company s attempt to patent a new version of its leukemia drug Gleev
stanley quencher uk ec on the basis that the drug is a new formulation of an existing drug.Although some Indian drug companies and groups say that Gleevec is a new formulation of a drug developed before 1995, Novartis says that it is an improved drug. If Novartis wins the case, it potentially could set a precedent for other pharmaceutical companies seeking patent protection for drugs, including antiretrovirals, some HIV/AIDS advocates have said. Novartis in May said it would wait for the court s ruling in the case before deciding how to proceed Kaiser Daily HIV/AIDS Report, 5/16 . The court in it